SUNHERE(SZ:300452) Xin Lang Cai Jing·2026-02-11 10:32Recent Events - The company announced on February 4, 2026, that it passed the on-site inspection by the U.S. Food and Drug Administration (FDA), covering six major systems including quality and production [1][3]. Stock Performance - Over the past 7 days (February 4 to February 11, 2026), the company's stock price exhibited volatility, reaching a peak of 17.14 yuan on February 5, followed by a correction. The latest closing price as of February 11 is 15.98 yuan, with a daily increase of 0.50% and a turnover rate of 5.12% [2][4]. - On February 10, there was a net outflow of 1.9898 million yuan from main funds, while retail and speculative funds saw net inflows of 1.5736 million yuan and 416,200 yuan, respectively, indicating sustained market activity [2][4]. - The technical analysis suggests that the stock is currently in a bullish trend, with a resistance level at 16.68 yuan and a support level at 14.53 yuan [2][4].